Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | PIM1 | P11309 | 4/20 | 0.35 |
| ▸ | PIM3 | Q86V86 | 4/20 | 0.35 |
| ▸ | KIF11 | P52732 | 3/20 | 0.33 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.33 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.33 |
| ▸ | PARP1 | P09874 | 2/20 | 0.32 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.31 |
| ▸ | DPYD | Q12882 | 1/20 | 0.30 |
| ▸ | AHR | P35869 | 1/20 | 0.30 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pavettine SCHEMBL36138 | 0.86 | KIF11 (0.53) | ALDH1A1PIM1PIM3KIF11PARP1 | |
| Pavettine SCHEMBL28686824 | 0.86 | KIF11 (0.53) | ALDH1A1PIM1PIM3KIF11PARP1 | |
| Pavettine SCHEMBL29450528 | 0.86 | KIF11 (0.53) | ALDH1A1PIM1PIM3KIF11PARP1 | |
| Pavettine SCHEMBL11798972 | 0.84 | KIF11 (0.52) | ALDH1A1PIM1PIM3KIF11PARP1 | |
| Pavettine SCHEMBL9643901 | 0.84 | KIF11 (0.52) | ALDH1A1PIM1PIM3KIF11AHR | |
| Pavettine SCHEMBL10336589 | 0.84 | KIF11 (0.52) | ALDH1A1PIM1PIM3KIF11PARP1 | |
| Pavettine SCHEMBL11349640 | 0.84 | KIF11 (0.52) | ALDH1A1PIM1PIM3KIF11PARP1 | |
| Pavettine SCHEMBL7027032 | 0.81 | KIF11 (0.49) | ALDH1A1PIM1PIM3KIF11AHR | |
| Pavettine SCHEMBL25415620 | 0.78 | KIF11 (0.46) | ALDH1A1PIM1PIM3KIF11AHR | |
| Pavettine SCHEMBL4350253 | 0.78 | KIF11 (0.46) | ALDH1A1PIM1PIM3KIF11AHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230250112-A1 | ORGANIC COMPOUNDS AND APPLICATIONS THEREOF IN OPTOELECTRONIC FIELD | Zhejiang Brilliant Optoelectronic Technology Co.,Ltd. (CN) | 2023-08-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230250112-A1 | ORGANIC COMPOUNDS AND APPLICATIONS THEREOF IN OPTOELECTRONIC FIELD | AOX1, AOC2, OR10J3 | ALDH1A1 80/4885PIM1 2961/4885PIM3 3003/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.